images (140×140)   Dow University of Health Sciences Library Catalogue

Welcome to Dow University of Health Sciences Library Online Public Access Catalog

The art of drug synthesis / (Record no. 27936)

MARC details
000 -LEADER
fixed length control field 02347nam a2200193Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250806s9999||||xx |||||||||||||| ||und||
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780471752158 (cloth);0471752150 (cloth)
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 744
Item number .A78 2007
245 #4 - TITLE STATEMENT
Title The art of drug synthesis /
Statement of responsibility, etc. edited by Douglas S. Johnson, Jie Jack Li.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Hoboken, N.J. :
Name of publisher, distributor, etc. Wiley-Interscience,
Date of publication, distribution, etc. c2007.
300 ## - PHYSICAL DESCRIPTION
Extent xv, 276 p. :
Other physical details ill.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer: exemestane (aromasin), anastrozole (arimidex), and letrozole (femara) / Jie Jack Li -- Quinolone antibiotics: levofloxacin (levaquin), moxifloxacin (avelox), gemifloxacin (factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals: itraconazole (sporanox), fluconazole (diflucan), voriconazole (vfend), and fosfluconazole (prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza: oseltamivir phosphate (tamiflu), and zanamivir (relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors /Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Pin??eiro-Nun??ez -- GABAA receptor agonists for insomnia: zolpidem (ambien), zaleplon (sonata), eszopiclone (estorra, lunesta), and indiplon / Peter R. Guzzo -- [alpha]2[delta] ligands: neurontin (gabapentin) and lyrica (pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder: amphetamine (adderall), methylphenidate (ritalin), and atomoxetine (stratterra) / David L. Gray.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemistry, Pharmaceutical
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Johnson, Douglas S.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Li, Jie Jack.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
-- DIMC
Koha item type Books
Holdings
Date last seen Total checkouts Full call number Barcode Price effective from Koha item type Lost status Damaged status Not for loan Withdrawn status Home library Current library Date acquired
08/06/2025   QV 744 .A78 2007 00002187 08/06/2025 Books         Dow International Medical College Dow International Medical College 08/06/2025



©2026, All rights reserved. Dow University of Health Sciences, Karachi, Pakistan.